RNU6-1174P

Across TCGA pan-cancer cohorts, RNU6-1174P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RNU6-1174P data layer.

The strongest signal is observed in thymoma (THYM), where higher RNU6-1174P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1174P expression acts as an unfavorable survival marker, although some lineages such as LAML and MESO show a favorable association.

THYM, UCEC, and READ are the cancer types where RNU6-1174P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	III,IV	0.103	0.944	<.001	81	view →
UCEC	DFS	Tertile	IV	0.181	0.705	.009	48	view →
READ	OS	Tertile	III,IV	0.330	0.900	<.001	36	view →
LAML	DFS	Tertile	All	0.720	0.302	.003	36	view →
OV	OS	Tertile	II,III,IV	0.766	0.848	.027	18	view →
KIRC	OS	Tertile	All	0.710	0.823	.003	18	view →
STAD	DFS	Tertile	All	0.424	0.568	.018	15	view →
LGG	OS	Tertile	All	0.640	0.854	.006	12	view →
THCA	OS	Tertile	All	0.928	0.984	.043	9	view →
BRCA	OS	Tertile	II,III,IV	0.918	0.961	.028	6	view →
MESO	DFS	Tertile	All	0.553	0.339	.039	6	view →
LIHC	OS	Tertile	All	1.000	0.678	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RNU6-1174P–THYM (OS)

Open the THYM breakdown →